Category: Pharma

Sun Pharma launches CEQUA®, a novel therapy for Dry Eye Disease in India. Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomb: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its … Read More

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” including its subsidiaries and/or associate companies), today announced that one of its wholly owned subsidiaries has received final approval from US … Read More

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata. Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715 (together with its subsidiaries and/or … Read More

Sun Pharma launches Palbociclib, a novel targeted therapy for advanced breast cancer with a unique Patient Assistance Program. Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, … Read More

 Sun Pharma is Great Place To Work Certified in India. Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is proud to announce that it is Great Place To Work® Certified™ in … Read More

Founded by Dr. Neerja Birla Mpower, an initiative of Aditya Birla Education Trust is a revolutionary social enterprise that provides holistic mental health care services in India. Mpower a leader … Read More

Apollo launches national Antimicrobial Stewardship program to promote rational use of antibiotics. Apollo, Asia’s foremost integrated healthcare services provider today announced the launch of an Antimicrobial Stewardship Programme (Apollo ASP) … Read More

Sun Pharma and SPARC enter into a license agreement for commercialization of phenobarbital for injection in the US. A wholly-owned subsidiary of Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, … Read More

Mankind Pharma Limited, India’s fourth largest pharmaceutical company in terms of Domestic Sales and second largest in terms of sales volume for FY22, has filed its Draft Red Herring Prospectus (“DRHP”) with market regulator … Read More